Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Margolskee

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Theoretical Biology|March 15, 2013
A lifelong model for the female reproductive cycle with an antimüllerian hormone treatment to delay menopauseAlison Margolskee, James F Selgrade
Mathematical Biosciences|September 24, 2011
Dynamics and bifurcation of a model for hormonal control of the menstrual cycle with inhibin delayAlison Margolskee, James F Selgrade
CPT: Pharmacometrics & Systems Pharmacology|July 23, 2019
Effective Visual Communication for the Quantitative ScientistMarc Vandemeulebroecke, Mark Baillie, Alison Margolskee, et al.
The Journal of Pharmacy and Pharmacology|October 27, 2016
Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic modelsSimone Hansmann, Adam Darwich, Alison Margolskee, et al.
The AAPS Journal|December 16, 2015
Deconvolution and IVIVC: Exploring the Role of Rate-Limiting ConditionsAlison Margolskee, Adam S Darwich, Aleksandra Galetin, et al.
Pharmaceutical Statistics|November 1, 2018
How can we make better graphs? An initiative to increase the graphical expertise and productivity of quantitative scientistsMarc Vandemeulebroecke, Mark Baillie, David Carr, et al.
Lipids in Health and Disease|October 4, 2024
Efficacy and safety of olezarsen in lowering apolipoprotein C-III and triglycerides in healthy Japanese AmericansEwa Karwatowska-Prokopczuk, Anastasia Lesogor, Jing-He Yan, et al.
Clinical Pharmacology and Therapeutics|October 25, 2022
Translational Population-Pharmacodynamic Modeling of a Novel Long-Acting siRNA Therapy, Inclisiran, for the Treatment of HypercholesterolemiaNathalie H Gosselin, Virna J A Schuck, Olivier Barriere, et al.
Journal of Clinical Lipidology|December 18, 2022
Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjectsEwa Karwatowska-Prokopczuk, Anastasia Lesogor, Jing-He Yan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2016
IMI - oral biopharmaceutics tools project - evaluation of bottom-up PBPK prediction success part 1: Characterisation of the OrBiTo database of compoundsAlison Margolskee, Adam S Darwich, Xavier Pepin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Theoretical Biology|March 15, 2013
A lifelong model for the female reproductive cycle with an antimüllerian hormone treatment to delay menopauseAlison Margolskee, James F Selgrade
Mathematical Biosciences|September 24, 2011
Dynamics and bifurcation of a model for hormonal control of the menstrual cycle with inhibin delayAlison Margolskee, James F Selgrade
CPT: Pharmacometrics & Systems Pharmacology|July 23, 2019
Effective Visual Communication for the Quantitative ScientistMarc Vandemeulebroecke, Mark Baillie, Alison Margolskee, et al.
The Journal of Pharmacy and Pharmacology|October 27, 2016
Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic modelsSimone Hansmann, Adam Darwich, Alison Margolskee, et al.
The AAPS Journal|December 16, 2015
Deconvolution and IVIVC: Exploring the Role of Rate-Limiting ConditionsAlison Margolskee, Adam S Darwich, Aleksandra Galetin, et al.
Pharmaceutical Statistics|November 1, 2018
How can we make better graphs? An initiative to increase the graphical expertise and productivity of quantitative scientistsMarc Vandemeulebroecke, Mark Baillie, David Carr, et al.
Lipids in Health and Disease|October 4, 2024
Efficacy and safety of olezarsen in lowering apolipoprotein C-III and triglycerides in healthy Japanese AmericansEwa Karwatowska-Prokopczuk, Anastasia Lesogor, Jing-He Yan, et al.
Clinical Pharmacology and Therapeutics|October 25, 2022
Translational Population-Pharmacodynamic Modeling of a Novel Long-Acting siRNA Therapy, Inclisiran, for the Treatment of HypercholesterolemiaNathalie H Gosselin, Virna J A Schuck, Olivier Barriere, et al.
Journal of Clinical Lipidology|December 18, 2022
Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjectsEwa Karwatowska-Prokopczuk, Anastasia Lesogor, Jing-He Yan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2016
IMI - oral biopharmaceutics tools project - evaluation of bottom-up PBPK prediction success part 1: Characterisation of the OrBiTo database of compoundsAlison Margolskee, Adam S Darwich, Xavier Pepin, et al.
Pageof 2